(GEG) Great Elm Group, Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(GEG) Great Elm Group, Inc. Complete Analysis Pack
This Great Elm Group, Inc. 4P's Marketing Mix Analysis summarizes Product, Price, Place, and Promotion to show how the company positions and sells its offerings; it’s designed for marketing research, strategy, and presentations. The page contains a real preview/sample of the report so you can review style and content—purchase the full version to get the complete ready-to-use analysis.
Product
Great Elm Group, Inc. runs its main offering set through 2 segments: durable medical equipment and investment management. In 2025, that mix paired patient-facing equipment services with fee-based capital management, giving the company both operating income and asset-based revenue. The structure helps it balance a healthcare services business with a finance platform.
PAP and ventilators sit at the core of Great Elm Group, Inc.'s respiratory support line, serving sleep apnea and breathing-care patients. PAP devices are the first-line treatment for obstructive sleep apnea, which affects an estimated 936 million adults worldwide, while ventilators support patients with severe respiratory failure. This makes the product mix clinical, recurring, and need-driven.
Great Elm Group, Inc. sells oxygen therapy units plus replacement parts and accessories, so the sale does not end at the first device purchase. The parts keep devices in use and create repeat demand, which helps lift recurring revenue. Great Elm Group, Inc. has not broken out 2025/2026 oxygen-parts sales publicly, so the exact run-rate is not disclosed.
Sleep studies and leases
Great Elm Group, Inc. includes diagnostic sleep studies in its service mix and also leases medical apparatus, so the product line goes beyond devices into care delivery and equipment access. That creates 2 linked revenue paths: testing services and lease income, which can support recurring patient and provider relationships.
- Sleep studies add diagnostic care
- Leases expand equipment access
- Mix shifts beyond devices
- Two revenue streams support breadth
Portfolio management
Great Elm Group, Inc.'s portfolio management service is its non-medical, finance-led product line, so it gives the Company a second revenue stream beyond healthcare-related assets. In its latest fiscal filings, the platform was part of a broader capital base of about $400 million in total assets, showing this service sits inside a scaled investment business, not a side offer.
- Serves financial clients, not patients
- Creates a second product category
- Supports fee and asset-based income
Great Elm Group, Inc.'s product mix is led by durable medical equipment: PAP devices, ventilators, oxygen therapy units, parts, and accessories. It also adds sleep studies and equipment leases, so revenue is not tied to one-time device sales. The finance side broadens the offer with portfolio management.
| Product | 2025 take |
|---|---|
| Medical devices | PAP, ventilators, oxygen |
| Services | Sleep studies, leases |
| Finance | Portfolio management |
| Scale | About $400M assets |
What is included in the product
Detailed Word Document
A concise, company-specific 4P analysis of Great Elm Group, Inc.’s Product, Price, Place, and Promotion strategy with real-world context.
Editable Excel File
Condenses Great Elm Group, Inc.’s 4Ps into a clear, at-a-glance summary for faster decision-making and easier stakeholder alignment.
Reference Sources
Great Elm Group, Inc. Reference Sources consolidates primary industry reports, government data, and benchmark studies to speed due diligence and verify key model assumptions.
Place
Great Elm Group, Inc.’s main corporate office is in Waltham, Massachusetts, and it serves as the company’s primary business base. This is the central site for management, oversight, and day-to-day executive control. For the 4P’s marketing mix, Waltham anchors the company’s place strategy by keeping leadership in one core location.
U.S. patient delivery should run through home-care and clinician channels, with reach across all 50 states so respiratory devices get to patients fast. For Great Elm Group, Inc., that means local service partners, stocked depots, and tracked delivery to cut delays. Same-day or next-day access matters most when patients need therapy now, not later.
Healthcare referral channels are the key route for Great Elm Group, Inc.'s durable medical equipment sales, because clinical and sleep-related providers connect patients to therapy devices and studies. In the U.S., sleep apnea affects roughly 30 million adults, so referral access can shape a large addressable pool. For a DME model, each confirmed referral is a direct path to utilization and reimbursement.
Direct client servicing
Great Elm Group, Inc. uses direct client servicing for investment management, so the firm works one-on-one with clients instead of using a broad retail channel. That fits a relationship-based model: trust, tailored mandates, and ongoing oversight matter more than volume. Its latest public filings show the business remains fee-led, so direct service supports stickier client ties and repeat mandates.
- Relationship-based, not retail-led
- Matches service-heavy asset management
- Supports tailored client mandates
- Helps retain recurring fee revenue
On-site and leased equipment
Great Elm Group, Inc. uses an on-site and leased equipment model, so place is the care site plus the service network that keeps devices running. That matters for medical devices because uptime, maintenance, and fast swaps shape daily use more than a sales office does. In practice, access and support drive the value of the asset.
- Deployment site is part of the channel
- Service support protects device uptime
- Leasing supports recurring medical use
Great Elm Group, Inc. is based in Waltham, Massachusetts, and that single headquarters anchors management and control. Its place strategy is service-led, with client work handled directly rather than through a wide retail network. For its healthcare-linked activities, access depends on the service site and delivery channel, not storefront traffic.
| Place factor | Great Elm Group, Inc. detail |
|---|---|
| Headquarters | Waltham, Massachusetts |
| Channel | Direct client servicing |
| Delivery model | Service site plus support network |
Preview the Actual Deliverable
Great Elm Group, Inc. Reference Sources
The preview shown here is the actual Great Elm Group, Inc. 4P's Marketing Mix analysis you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.
Promotion
Great Elm Group uses SEC filings, earnings releases, and shareholder letters as its main promotion channel, so investors get strategy and results straight from the source.
That matters because public companies face 10-K, 10-Q, and 8-K disclosure rules, which give the market a steady flow of updates on business shifts and financial performance.
For Great Elm Group, those disclosures help build awareness, shape expectations, and keep shareholders informed without paid media.
With over 5.5 billion internet users worldwide in 2025, Great Elm Group, Inc. can use its corporate website to promote both business lines at very low cost. It gives investors and clients one place to find brand, service, and filing details, which cuts friction and supports trust. For a public company, this channel is especially useful because it can update content fast without the cost of print or paid media.
Physician referrals can drive medical device demand because clinicians often shape treatment choice and timing. For Great Elm Group, Inc., that makes provider ties a direct promotion channel, with the message centered on patient need, clinical fit, and treatment support. In U.S. healthcare, 1.0 billion+ physician-patient visits a year keep referral networks active and highly influential.
Healthcare partner outreach
Great Elm Group, Inc. promotes durable medical equipment through healthcare partner outreach, since sleep labs, clinicians, and care coordinators can shape device referrals, study flow, and lease adoption. This channel matters because trusted partners often drive the first patient touchpoint, so outreach can lift awareness and conversion without heavy direct spending.
Sleep labs feed device demand.
Clinicians drive referral trust.
Care coordinators help lease uptake.
2020 rebrand
The December 2020 name change to Great Elm Group, Inc. worked as a promotion move because it refreshed market identity and made the company easier to recognize. It also helped pull the medical and investment businesses under one brand, which can improve message clarity. Rebrands often act like a market signal, and this one did so at a key corporate reset point.
- Dec 2020: new company name
- One name, two business lines
- Signals refreshed positioning
Great Elm Group, Inc. promotes through SEC filings, earnings releases, shareholder letters, and its website, which keeps the message low-cost and direct. In 2025, more than 5.5 billion people used the internet, so the website remains a cheap reach tool. Provider outreach also supports its medical business by steering referrals and lease adoption. The 2020 name change still helps brand clarity.
| Channel | Why it matters |
|---|---|
| SEC filings | Direct investor updates |
| Website | Low-cost brand reach |
| Provider outreach | Drives referrals |
Price
Insurance reimbursement drives Great Elm Group, Inc.'s durable medical equipment pricing, because Medicare Part B usually covers 80% of approved costs after the deductible, and many DME items use capped rentals that can run up to 13 months. That means the real price is set by payer rules, not sticker price. In 2025, pricing stays tied to fee schedules and prior-authorization checks.
Great Elm Group, Inc. leases certain medical apparatus, so rental-based equipment fees can be billed as recurring monthly payments instead of a one-time sale. That model supports steadier revenue and lower upfront cost for customers, which helps access and retention. Public 2026 fee detail was not disclosed in the source set, so the pricing is best read as subscription-like, not fixed unit pricing.
Great Elm Group, Inc. does not disclose a material "accessory and parts" price stream in its 2025 filings, so this 4P is not a key revenue lever for the Company. Its latest reported revenue mix is driven by investment and asset-based fees, not repeat sales of consumables or replacement parts. That means there is little evidence of the kind of add-on pricing used by device makers to capture repeat purchase value.
Sleep-study service fees
Sleep-study service fees turn diagnostic testing into a fee-based revenue stream for Great Elm Group, Inc. The price covers overnight monitoring, technician time, and physician review, so margins depend on utilization and payer mix. CMS updates hospital outpatient payments each year, so fee levels can shift with 2025-2026 reimbursement rules.
- Fee-based medical revenue
- Covers testing and clinical support
- Reimbursement drives pricing
Management fee model
Great Elm Group, Inc. prices its investment management arm mainly through fees, usually a mix of management fees and related service charges. That makes it a fee-based model, unlike Great Elm Group, Inc.'s healthcare pricing, which is tied more to patient services and reimbursement.
- Fee-based, not per-unit pricing
- Management and service charges
- More scalable than healthcare
Great Elm Group, Inc.'s price is mostly reimbursement-led, not sticker-led: Medicare Part B typically pays 80% after the deductible, and capped DME rentals can run up to 13 months. In 2025-2026, fee schedules and prior auth set the real price.
| Price driver | 2025/2026 view |
|---|---|
| Medicare share | 80% |
| Capped rental term | Up to 13 months |
| Pricing basis | Fee schedules |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
